Document ID: chunk:federal_register_of_legislation:F2017L00003:reg:9:p2
Version: federal_register_of_legislation:F2017L00003
Segment Type: reg
Provision Reference: reg 9 (pt 2/4)
Character Range: 6150–8970

of chronic infection with schistosomiasis involving the liver before the clinical onset of cirrhosis of the liver;
(13)      having granulomatous liver disease before the clinical onset of cirrhosis of the liver;
Note: granulomatous liver disease is defined in the Schedule 1 - Dictionary.
(14)      having severe right-sided cardiac failure for a continuous period of at least 12 months, within the five years before the clinical onset of cirrhosis of the liver;
Note: severe right-sided cardiac failure is defined in the Schedule 1 - Dictionary.
(15)      having veno-occlusive disease for a continuous period of at least 12 months, within the five years before the clinical onset of cirrhosis of the liver;
Note: veno-occlusive disease is defined in the Schedule 1 - Dictionary.
(16)      having a chronic partial or complete blockage to the passage of bile from the intrahepatic biliary system to the duodenum at the time of the clinical onset of cirrhosis of the liver;
(17)      having iron overload involving the liver at the time of the clinical onset of cirrhosis of the liver;
Note: iron overload is defined in the Schedule 1 - Dictionary.
(18)      having alpha-1 antitrypsin deficiency before the clinical onset of cirrhosis of the liver;
(19)      having Gaucher's disease before the clinical onset of cirrhosis of the liver;
(20)      having Wilson's disease before the clinical onset of cirrhosis of the liver;
(21)      having Budd-Chiari syndrome for a continuous period of at least 12 months, within the five years before the clinical onset of cirrhosis of the liver;
Note: Budd-Chiari syndrome is defined in the Schedule 1 - Dictionary.
(22)      consuming a daily average of at least 15 milligrams of vitamin A for a period of at least 18 months, or a cumulative dose of at least eight grams, within the ten years before the clinical onset of cirrhosis of the liver;
(23)      being treated with methotrexate:

(a)           for at least the 12 months; or
(b)           to a cumulative dose of methotrexate of at least one gram taken over at least a six month period,
         before the clinical onset of cirrhosis of the liver;
(24)      being treated with dideoxynucleoside-analogue drugs as specified for at least 12 months before the clinical onset of cirrhosis of the liver;
Note: dideoxynucleoside-analogue drugs as specified is defined in the Schedule 1 - Dictionary.
(25)      inhaling or having cutaneous contact with carbon tetrachloride for a cumulative period of at least 1 000 hours within the five years before the clinical onset of cirrhosis of the liver;
(26)      for males, consuming at least 150 kilograms of alcohol within any ten year period before the clinical worsening of cirrhosis of the liver;
Note: alcohol is defined in the Schedule 1 - Dictionary.
(27)      for females,